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Chloroplast TatBThe chloroplast twin arginine translocation (cpTat) system transports highly folded precursor proteins into
the thylakoid lumen using the protonmotive force as its only energy source. Hcf106, as one of the core
components of the cpTat system, is part of the precursor receptor complex and functions in the initial
precursor-binding step. Hcf106 is predicted to contain a single amino terminal transmembrane domain followed
by a Pro-Gly hinge, a predicted amphipathic α-helix (APH), and a loosely structured carboxy terminus. Hcf106
has been shown biochemically to insert spontaneously into thylakoid membranes. To better understand the
membrane active capabilities of Hcf106, we used solid-state NMR spectroscopy to investigate those properties
of the APH. In this study, synthesized peptides of the predicted Hcf106 APH (amino acids 28–65) were
incorporated at increasing mol.% into 1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine (POPC) and POPC/
MGDG (monogalactosyldiacylglycerol; mole ratio 85:15) multilamellar vesicles (MLVs) to probe the peptide–
lipid interaction. Solid-state 31P NMR and 2H NMR spectroscopic experiments revealed that the peptide perturbs
the headgroup and the acyl chain regions of phospholipids as indicated by changes in spectral lineshape,
chemical shift anisotropy (CSA) line width, and 2H order SCD parameters. In addition, the comparison between
POPC MLVs and POPC/MGDG MLVs indicated that the lipid bilayer composition affected peptide perturbation
of the lipids, and such perturbation appeared to bemore intense in a systemmore closely mimicking a thylakoid
membrane.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
In plant cells most thylakoid lumen proteins are synthesized in the
cytosol as higher molecular weight precursors containing targeting
sequences, which allow import into chloroplasts and localization to
thylakoid lumen for function [1,2]. Two thylakoid transport systems,
homologous to bacteria export systems, direct precursors to the
thylakoid lumen [3]. The chloroplast Sec system transports largely
unfolded proteins across the membrane in an ATP dependent manner,
while the chloroplast twin arginine translocation (cpTat)2 system
delivers highly folded proteins across the membrane utilizing the trans-
thylakoidal protonmotive force as its only energy source. Another
distinguishing feature of Tat transport system is the presence of a twin
arginine amino acid motif in the lumen-targeting signal peptide of thensport; TMD, transmembrane
oyl-sn-glycero-phosphocholine;
r vesicles; CSA, chemical shift
try and Biochemistry, Miami
1 513 529 8091.
ith).
physics, Texas A&M University,
ights reserved.precursor, which gives the pathway its name. The cpTat pathway consists
of three core membrane-bound subunits, Tha4, Hcf106, and cpTatC,
whereas the homologous proteins in the bacterial Tat system are TatA,
TatB and TatC [2]. Sequence analysis predicts that Tha4 (TatA) and
Hcf106 (TatB) have similar structure, both consisting of an N-terminal
transmembrane domain (TMD), followed by an amphipathic helix
(APH) and an unstructured C-terminus (C-tail) [4]; however, the APH
domain and C-tail region of Hcf106 are approximately two times larger
than those of Tha4. The predicted structure for Tha4has been conﬁrmed
by determination of the structure of a truncated version of the
homologous protein, TatAd (2–45), from Bacillus subtilis by solution
NMR [5] and solid-state NMR [6]. Even though Tha4 and Hcf106 appear
to have structural similarities, this has not been investigated directly. In
addition the two proteins are functionally distinct such that one cannot
functionally replace the other [4]. cpTatC is an integral membrane
protein with six transmembrane-spanning helices [7,8]. Nuclear genes
encode all three proteins, and they are synthesized in the cytoplasm
as larger molecular weight precursors containing N-terminal amino
acid extensions, the stromal-targeting transit peptides. cpTatC is
localized to the thylakoid via a stromal intermediate [9], and it cannot
integrate into the thylakoid membrane directly. Conversely, Tha4 and
Hcf106 do not appear to use a stromal intermediate, and they can
integrate directly into thylakoid membranes even in the absence of
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into the membrane spontaneously or unassisted is unknown. Here we
investigated interactions of a synthetic peptide corresponding to the
APH region of Hcf106 for its ability to interact with multilamellar
vesicles (MLVs) as insight into the ability to spontaneously insert into
thylakoid membranes. Understanding Hcf106 interaction with lipid
bilayers may also provide insights into Hcf106 function and activity.
One way to better understand the integration, topology, and
structure–function relationships of membrane proteins is to study the
interaction between the peptide and lipids by solid-state NMR
spectroscopy. Solid-state NMR techniques are widely used to study
the structural and dynamic properties of peptides and lipids [10–13].
31P and 2H solid-state NMR spectroscopy are useful probes to study
peptide–lipid interactions from the perspective of lipids. Utilizing 31P
as a natural probe, which is sensitive to the conformation of lipid
headgroup, lipid phase and electrostatic property, 31P NMR is
extensively used to investigate the dynamics and interaction between
lipid headgroups with peptides [14–16]. Complementary to 31P NMR,
2H solid-state NMR spectroscopy provides information on the
orientation and dynamics of the acyl chains of lipids by incorporating
peptides or proteins into acyl-chains deuterated phospholipid bilayers
[17–19]. Peptide–lipid interactions are based on the amino acid sequence
of proteins and the composition of lipids, and are widely used to address
questions such as protein and lipid structure, hydrophobicity and
aggregation of proteins, charge distribution on lipid, depth of peptide
in the lipid milieu, and modulation of interaction by altering the lipid
composition [20–23]. Unlike small micelles with high curvature, which
could hardly retain native structure of peptides, multilamellar vesicles
(MLVs) are more membrane-mimicking systems that are composed of
multi-layers of lipid bilayers [24,25].
Herewe use solid-state NMR spectroscopy to investigate the topology
of vesicles from the perspective of the lipids, obtaining preliminary
topology information of Hcf106 in lipids by studying the peptide–lipid
interaction. To simplify the study of this 176 amino acid protein, a peptide
encompassing the APH (residues 28–65) of Hcf106 were synthesized by
Fmoc-based solid-phase methods and puriﬁed by high-performance
liquid chromatography [26]. These peptides were then incorporated
into POPC (1-palmitoyl-2-oleoyl-sn-glycero-phosphoatidylcholine)
and POPC/MGDG (monogalactosyldiacylglycerol) vesicles at various
concentrations. The synthetic phospholipid bilayers mimicked biological
membranes providing a controlled environment in which to assay
peptide interaction or insertion with the membrane. A peptide from the
C terminus of the small subunit of Rubisco (mSSU Rubisco)was predicted
to be non-amphipathic by standard algorithms, andwas used as a control
peptide in this study. Using 31P NMR spectroscopy we showed that
Hcf106 APH peptides interact with phospholipid headgroups. In addition
2H NMR spectroscopic measurements revealed the perturbation of the
deuterated acyl chains by the presence of peptide and the effect of lipid
composition on the peptide–lipid interaction. Further, the order
parameter SCD from 2H NMR demonstrated the dynamic characteristics
of lipid headgroup and acyl chain and the effect of peptide addition to
the vesicles. These experimental results conﬁrmed the membrane-
associate activity of the proposed amphipathic helix of Hcf106 and
suggested that Hcf106 mostly sat on the membrane surface and
perturbed the hydrophobic region of phospholipid to a lesser extent.
2. Materials and methods
2.1. Materials
Synthetic phospholipids POPC and POPC-d31 were purchased from
Avanti Polar Lipids (Alabaster, AL). Natural galactolipid from parsley
leaves, MGDG, was purchased from Larodan Fine Chemicals AB
(Sweden). All lipids were dissolved in chloroform or chloroform/
methanol and stored at −20 °C under N2 gas until use. Fmoc amino
acids were purchased from Novabiochem (San Diego, CA). Peptidesynthesis resin and other chemicals for synthesis were purchased from
Applied Biosystems (Foster City, CA). HPLC grade acetonitrile was
purchased from VWR (Radnor, PA) and was ﬁltered through a 0.22-mm
nylon membrane before use. Water was puriﬁed using a Nanopure
reverse osmosis system (Millipore, Bedford, MA). Chloroform, piperidine,
EDTA, N-[2-hydroxyethyl] piperazine-N″-2-ethane sulfonic acid (HEPES)
and 2,2,2 triﬂuoroethanol (TFE) were purchased from Sigma-Aldrich
(Milwaukee, WI). The deuterium-depleted water was purchased from
Isotec (Miamisburg, OH).
2.2. Synthesis and puriﬁcation of peptide Hcf106 APH and peptide
mSSU Rubisco
Hcf106 APH and mSSU Rubisco were synthesized using Fmoc solid-
phase peptide synthesize chemistry on a CEM microwave peptide
synthesizer (Matthews, NC). The sequence for the amphipathic helix of
Hcf106 is NH2-LAEVARNLGKTLREFQPTIREIQDVSREFKSTLEREIG-COO−,
while the sequence for the control peptide mSSU Rubisco is NH2-
EHNKSPRYYDGRYWTMWKLPMFGTTDASQVLG-COO−. After the peptides
were cleaved from their solid support, they were puriﬁed via HPLC on a
C18 reverse-phase preparation column. The column was equilibrated
with 95% solvent A (100% H2O) and 5% solvent B (60% acetonitrile, 40%
H2O for Hcf106 APH; 90% acetonitrile, 10% H2O for mSSU Rubisco), and
was eluted with a linear gradient of 5–95% solvent B. The buffers also
contained 0.1% triﬂuoroacetic acid (TFA). The puriﬁed peptide was
lyophilized to remove existing solvent. Purity was conﬁrmed by matrix-
assisted laser desorption ionization time-of-ﬂight (MALDI-TOF) mass
spectrometry to ensure the purity of the peptides.
2.3. NMR sample preparation
POPC bilayers containing Hcf106 APH peptide of various
concentrations were prepared as described [15]. Brieﬂy Hcf106 APH
peptide (2.0–6.1 mg) and POPC bilayers (17.5 mg) were dissolved in
2,2,2 triﬂuoroethanol and chloroform, respectively, and the peptide was
added to the lipids at the mol.% indicated in the ﬁgure legends. The
mixtures were dried under steady N2 gas and placed in a vacuum
desiccator overnight to remove residual solvent. The multilamellar
vesicles (MLVs) were prepared by suspension of the dried mixture in
95 μl HEPES buffer (30 mM HEPES, pH 7.0, 5 mM EDTA, 20 mM NaCl)
followed by ﬁve cycles of moderate vortexing for 2 min, freezing with
liquid N2 for 1 min and sonication for 5 min in a 45 °C bath sonicator.
While the presence of residual TFA from the cleavage reaction should be
minimized, the presence of residual TFAwould lower the pHof the buffer,
especially given the small volume of dilute buffer added; therefore, the
peptide solution may have a pH b7.0. The fully homogenized samples
were transferred to NMR sample tubes. Peptide incorporation into
POPC/MGDG MLVs (85%:15% ratio) were prepared following the same
procedure, maintaining the total lipid amount at 17.5 mg. For the 2H
NMR experiments, 5 mg POPC-d31 phospholipids replaced the same
amount of non-deuterated POPC in the sample to maintain total lipid
amount (17.5 mg). POPC and POPC/MGDG MLVs containing 6 mol.%
control peptide from the SSU of Rubisco (5.3mg) were prepared by the
same procedure.
2.4. NMR spectroscopy
All NMR data were recorded on a Bruker Avance 500MHzWB NMR
spectrometer equipped with a CPMAS probe (Bruker, Billerica, MA). 31P
NMR spectra were acquired at 202.4MHzwith proton decoupling using
a 4μs 90° pulse and a 4s recycle delay. For the 31P static NMRspectra 512
scans were taken and the free induction delay was processed using
200Hz of line broadening. The spectral width was set to 500 ppm. All
31P NMR spectra were referenced by assigning the 85% H3PO4 31P peak
to 0ppm.
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quadrupolar echo pulse sequence using quadrature detection with
complete phase cycling of the pulse pairs. The 90° pulse length was 4 μs,
the interpulse delaywas 40μs, the recycle delaywas 0.4s, and the spectral
width was set to 100 kHz. For the 2H static NMR spectra 122,880 scans
were taken and were processed using 200 Hz of line broadening.
Powder-type 2H NMR spectra were deconvoluted (dePaked) using the
algorithm of McCabe and Wassall [27] such that the bilayer normal was
perpendicular with respect to the direction of the static magnetic ﬁeld.
The quadrupolar splittings were measured from the dePaked spectra,
and the 2H order parameters SCD were calculated according to the
equation SCDi=Δvi/(3/2(e2qQ/h)), where SCDi is the quadrupolar splitting
for a deuteron attached to the ith carbon of the POPC acyl chain, and
e2qQ/h is the quadruple coupling constant (168 kHz for deuteron in
C–D bonds). The order parameters of the methyl groups at the terminal
acyl chain were multiplied by three as the calculated values [28].
3. Results and discussion
3.1. 31P NMR studies indicate Hcf106 APH interaction with MLVs
Chloroplast Tat component Hcf106 is predicted to contain an N-
terminal proximal amphipathic α-helix (Fig. 1A), which has not been
characterized experimentally. In addition, previous studies suggest that
Hcf106 has the ability to insert into the thylakoid via the spontaneous
pathway, requiring nomembrane bound protein assistance or additional
energy, either in the form of nucleotide triphosphate hydrolysis or
transmembrane protonmotive force [4]. To better understand the ability
of Hcf106 to interact with membranes, we investigated the membrane
interactivity of one of the key predicted membrane active components,
the APH, using a synthetic peptide (Fig. 1A). Helical wheel projections
of the APH peptide used in this study clearly indicate the presence of a
hydrophilic face and a hydrophobic face of the helix (Fig. 1B).
To investigate the nature of lamellar and nonlamellar phase
transitions exhibited by the POPC MLVs in the presence of the Hcf106Fig. 1. Schematic of Hcf106 and peptide used in this study. Peptideswere synthesized on a CEM
chemistry as described in Materials and Methods. (A) A schematic of Hcf106 showing the diffe
(B) Helical wheel plot (DNAStar, Madison, WI) of the amino acids of the Hcf106 APH peptide iAPH peptide, static 31P NMR spectroscopic measurements were made
(Fig. 2A). The Hcf106 APH peptide concentration was varied from 0 to
6mol.% with respect to POPC lipids. As expected for POPC bilayers at a
temperature above the chain melting transition temperature (Tm) of
−2 °C [29], all spectra displayed a motionally averaged powder-
pattern at 25 °C, indicating that the phospholipid bilayers are in the
liquid crystalline phase (Fig. 2A). Increasing amounts of Hcf106 APH
peptide incorporated into POPC MLVs caused a corresponding increase
in the static lineshape width of the 31P NMR spectra as compared to
the lineshape width of the empty POPC vesicles (Fig. 2A). Furthermore,
the addition of the peptide caused a corresponding decrease in the
chemical shift anisotropy (CSA, σ‖ − σ⊥) line widths. CSA line widths
were measured for control vesicles and vesicles containing 6 mol.%
APH peptide (Fig. 2A) and were found to be 45 ± 1 ppm and 42 ±
1 ppm, respectively. There was a 3 ppm decrease in CSA line width
when 6mol.% peptide was added as compared to control POPC bilayers,
indicating that the headgroup region of the phospholipid bilayer was
perturbed by the addition of Hcf106 APH peptide. This change contrasts
directly with a CSA line width measure of 45±1 ppm in the presence
of 6 mol.% control peptide (Supplemental Fig. 1A), which was
indistinguishable from control vesicles.
The Hcf106 APH peptide is derived from the thylakoid localized
Hcf106 protein. Thylakoid membrane has a very high proportion of
nonphospholipids to phospholipids as well as a high proportion of the
nonbilayer forming lipid, monogalactosyl diacylglycerol (MGDG) that
can compose N50% of thylakoid lipid [30]. To more closely mimic the
native thylakoid lipid composition, we tested Hcf106 APH interaction
with vesicles containing 15 mol.% MGDG. In this synthetic system, we
were able to easily generate vesicles containing 15mol.% MGDG (85:15
mole ratio POPC:MGDG), but higher concentrations yielded unstable
vesicles and were not used for this study. When increasing amounts of
the Hcf106 APH peptide were incorporated into POPC/MGDG MLVs,
the corresponding 31P lineshape broadened compared to that of control
POPC/MGDG MLVs (Fig. 2B). As with POPC MLVs, the CSA widths
decreased as more peptide was added to the POPC/MGDG MLVs.microwave peptide synthesizer (Matthews, NC) using Fmoc solid-phase peptide synthesis
rent domains. The amino acid sequence of the peptide representing the APH is indicated.
ndicating the hydrophilic and hydrophobic faces.
Fig. 2. Hcf106 APH preferentially perturbs POPC/MGDG MLVs. (A) 31P spectra of MLV
samples showing the effect of Hcf106 APH on 31P spectra line shape of POPC bilayers as
a function of Hcf106 APH peptide concentration. (B) 31P spectra of MLV samples showing
the effect of Hcf106 APH on 31P spectra line shape of POPC/MGDG bilayers (85%:15%) as a
function of Hcf106 APH concentration at 25 °C. MLV samples of different lipids in the
absence of Hcf106 APH, and in the presence of 2, 4, and 6mol.% Hcf106 APH with respect
to lipids were investigated.
Fig. 3. Hcf106 APH interacts with the bilayer of POPC or POPC/MGDG MLVs. 2H NMR
spectra of MLV samples showing the perturbation of Hcf106 APH on lipids acyl chain of
(A) POPC bilayers, and (B) POPC/MGDG bilayers as a function of Hcf106 APH
concentration at 25 °C. POPC-d31 phospholipids (5 mg) were used as deuterium probe.
MLV samples of different lipids in the absence of Hcf106 APH, and in the presence of 2,
4, and 6mol.% Hcf106 APH with respect to lipids were investigated.
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6 mol.% APH peptide were 45 and 41 ppm, respectively. There was a
4 ppm decrease in CSA width when 6 mol.% peptide was added when
compared to the empty vesicles. However the presence of the control
peptide with POPC/MGDG vesicles resulted in a CSA line width of
45 ± 1 ppm, the same as control vesicles (Supplemental Fig. 1B). The
most obvious difference in 31P spectra lineshape between the POPC
MLVs and the POPC/MGDG MLVs was the appearance of an isotropic
peak that increased in intensity as the concentration of Hcf106 APH
was increased (Fig. 2B). The presence of such an isotropic peak suggests
that smaller vesicles were induced to form due to the presence of the
APH peptides and the contribution from the isotropic phase increased
as more Hcf106 APH was incorporated [31].
At least three possible occurrences can explain this change in CSA
line width: (1) increased stochastic ﬂuctuations experienced by the
lipid head groups due to an increase in the disorder of individual lipids
caused by the increasing presence of the APH, but not the control,
peptide; (2) increased axial rotationalmotion aswell as lateral diffusion
rate of lipid upon peptide incorporation; or (3) increased dynamics of
the vesicles, resulting from the interaction between the peptide and
head groups of the phospholipids [13,32–34]. However, an increase in
the long axis rotation of the lipid would be unlikely to affect the CSA
linewidth because at the point atwhich the 31P CSA linewidth becomes
axially symmetric it has reached an average and increasing the rotationat that point will not change those averages. In addition, an increase in
the lateral diffusion rate of the lipid is also unlikely to be large enough
to affect the CSA line width. More likely the change in CSA line width
is due to an increase in the disorder of the individual lipids as the
amount of the APH, but not the control, peptide increases. For example,
a decrease in the CSA line width may correspond to a change in the
orientation of the head groups of the lipid such that they are less upright
(i.e., the angle ϑx of the chemical shift tensor increases from the lipid
axis of rotation perpendicular to the plane of the phosphorous and
oxygens [35]). Regardless, the shift in CSA when the APH peptide was
present indicates a perturbation of the liquid crystalline array of the
lipids, and a change in averaged orientation of the lipid head groups
with respect to the bilayer normal, induced by rotational motion of
lipid head group [32,36]. Regardless, the APH peptide interacted with
MLVs containing the thylakoid-speciﬁc lipid, MGDG, more intensely as
compared to MLVs containing only POPC.3.2. 2H NMR studies indicate perturbation of POPC and POPC/MGDG lipids
acyl chain upon Hcf106 APH incorporation
Because static 31P NMR spectra only reﬂect the perturbation of the
peptide to the phospholipid headgroup, 2H solid-state NMR spectroscopy
was utilized to investigate the effect of increasing concentration ofHcf106
APH peptide on the order and dynamics of the acyl chain of POPC-d31
phospholipid in POPC and POPC/MGDGMLVs (Fig. 3). All spectra display
Fig. 4. Hcf106 APH preferentially disturbs the lipid head group/acyl chain interface.
Smoothed acyl chains orientational order SCD proﬁles calculated by DePaking 2H NMR
spectra of Fig. 3. POPC MLVs (A) and POPC/MGDG MLVs (B) with and without Hcf106
APH at various concentrations. SCD proﬁles calculated in the absence (●) or presence of
Hcf106 APH at 2mol.% (▲), 4mol.% (■) and 6mol.% (♦), respectively.
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the C–D bond closest to the glycerol backbone and the central splitting
arising from the terminal methyl group [13,31,34]. Clearly, addition of
APH peptide at various concentrations altered the line shape and
resolution of 2H NMR spectra of the POPC/POPC-d31 MLVs signiﬁcantly
compared to the control sample lacking peptide (Fig. 3A). The spectral
widths decreased upon addition of the APH peptide, indicating an
increase in the lipid bilayer ﬂuidity caused by perturbation of lipid
acyl chains upon peptide incorporation. As the concentration of APH
peptide increased there was a loss of resolution of the spectrum as
demonstrated by the disappearance of sharp edges of the peaks, also
revealing an interaction between the APH peptide and the acyl chains
of the lipid bilayer. In addition, this interaction increased the motion
of the lipids and/or the dynamics of the vesicles, as evidenced by the
increased isotropic peak intensity induced by higher amounts of APH
peptide. Similar to the presence of an isotropic peak in the 31P NMR
measurements, the increased dynamics of the vesicles could be
explained by the formation of small, rapidly tumbling vesicles [31].
The spectral line shape and isotropic component was even more
pronounced when Hcf106 APH peptides were added to POPC/POPC-
d31/MGDG MLVs (Fig. 3B). In contrast the line shape widths of the
MLVs (either POPC/POPC-d31 or POPC/POPC-d31/MGDG) were not
changed from those of the control vesicles when in the presence of
the control peptide (Supplemental Fig. 2), although the presence of
the control peptide did cause the formation of an isotropic peak.
Taken with the static 31P NMR data, these data indicate that the
Hcf106 peptide interacts with the POPC/MGDG vesicles, and does so
in the same way as it interacts with the POPC vesicles.
However the changes in CSA linewidths and in the 2H NMR spectral
line shapes due to the presence of the peptide were not very large
(barely 10% change) and may be a reﬂection of how the peptide can
engage the membrane. In vesicles containing the thylakoid-speciﬁc
lipid, the APH peptide may be a membrane breaching peptide at high
enough concentrations, similar to antimicrobial peptides, and this is
evidenced by the increasing presence of the isotropic peak with
increasing peptide amount. The presence of the MGDG lipid may
enhance the membrane breaching capabilities of the APH peptide due
to its tendency to not form a lamellar bilayer but rather to form a
nonlamellar, inverted Hexagonal (Hexagonal II) phase.
All 2H NMR powder pattern spectra were dePaked to probe the
dynamic changes of the acyl chains upon Hcf106 APH peptide
incorporation. SCD order parameters are sensitive to intermolecular,
intramolecular and collective motions, reﬂecting the orientation
and dynamic change of the C–D bond vector [37,38]. The smoothed
segmental C–D bond order parameters (SCD) were calculated from the
dePaked spectra and plotted as a function of acyl chain carbon number
for the different APH concentration at 25°C (Fig. 4). As distance from the
glycerol backbone increased, therewas a decrease of SCD for all samples,
indicating increased motion and ﬂexibility for the central and terminal
acyl chain regions as compared to the proximal headgroup region
(Fig. 4A, ﬁlled circles). In the presence of 2, 4 and 6mol.% APH peptides,
the acyl chains of POPC lipid bilayersweremoremobile compared to the
control vesicles lacking peptide or vesicles containing the control
peptide, as revealed by a decrease in the order of each C–D bond
(Fig. 4A). In the presence of theAPHpeptide, therewas a larger decrease
in the SCD for the ﬁrst three or four carbons from the ester than at the
methyl end of the acyl chains (Fig. 4A). Combined with the 31P NMR
data, these data suggest that Hcf106 APH peptide mostly sits on the
membrane surface or may slightly tilt into the hydrophobic region of
the phospholipid bilayers to interact with acyl chains in close proximity
to glycerol backbones. It is also possible that Hcf106 APH peptide
attached to the membrane surface by its hydrophilic face and induced
a relatively compact environment on the membrane surface and
more dynamic space in the hydrophobic region of the lipids. Further
experiments are needed to verify these explanations. The SCD proﬁle
for POPC/MGDG MLVs (Fig. 4B) resembles that in POPC MLVs, exceptthat POPC MLVs demonstrate a slightly larger SCD and less perturbation
caused by the incorporation of Hcf106 APH peptide.
4. Conclusion
This solid-state NMR study clearly shows lipid–peptide interaction.
31P and 2H solid-state NMR static spectra lineshape, CSA widths, and
2H order parameters are utilized to investigate lipid–peptide interaction
and the results are complimentary to each other. These data indicate that
Hcf106 APH peptide interacts with the head group and acyl chains of
phospholipid bilayers. The manipulation of the lipid composition clearly
alters the line shape of the spectra, and the peptides interact more
intensely with the thylakoid membrane-mimicking environment
(POPC/MGDG MLVs). These data show for the ﬁrst time that Hcf106
APH is by itself a membrane associated peptide, and also imply how
the peptide could arrange itself to interactwith lipidswhen incorporated
into membrane systems.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2013.10.007.
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